Skip to main content
. 2023 Nov;29(11):2189–2197. doi: 10.3201/eid2911.230598

Table 1. Baseline characteristics, clinical features, and laboratory, and imaging findings for patients with Campylobacter fetus infections, Nord Franche-Comté Hospital, Trévenans, France, 2000–2021*.

Characteristics All patients, n = 33 Patients without documented C. fetus bacteremia, n = 12† Patients with
documented C. fetus bacteremia, n = 21
p value
Baseline
Sex 0.7
M 18/33 (54) 6/12 (50) 12/21 (57)
F 15/33 (45) 6/12 (50) 9/21 (43)
Age, y (SD) 73 (±18) 66 (±19) 77 (±16) 0.12
Underlying comorbidities 27/33 (82) 8/12 (67) 19/21 (90) 0.2
Immunosuppression 13/33 (39) 2/12 (16) 11/21 (52) 0.06
Malignancy/cancers 8/33 (24) 1/12 (8.3) 7/21 (33) 0.2
Transplantation 0/33 0/12 0/21
Cirrhosis 1/33 (3.0) 0/12 1/21 (4.8) >0.9
HIV infection 0/33 0/12 0/21
Connective tissue disease‡ 3/33 (9.0) 1/12 (8.3) 2/21 (9.5) >0.9
Other§ 1/33 (3.0) 0/12 (8.3) 1/21 (29) >0.9
Prosthetic heart valves 8/33 (24) 4/12 (33) 4/21 (19) 0.4
Renal failure 7/33 (21) 1/12 (8.3) 6/21 (29) 0.2
Diabetes mellitus 12/33 (36) 5/12 (42) 7/21 (33) 0.7
Cardiovascular disease¶ 20/33 (61) 5/12 (42) 15/21 (71) 0.14
Recent abdominal surgery 1/33 (3.0) 0/12 1/21 (4.8) >0.9
Pregnancy 0/33 0/12 0/21
Contact with livestock/cattle 0/31 0/11 0/20
Poultry consumption 0/31 0/11 0/20
Recent travel# 1/31 (3.2) 1/11 (9.1) 0/20 0.4
Similar cases in household/entourage 0/31 0/11 0/20
Recent abdominal trauma injury 4/31 (13) 2/11 (18) 2/20 (10) 0.6
Transmission or contamination, food or pet
2/31 (6.5)
0/11
2/20 (10)
0.5
Clinical features
Fever 21/32 (66) 8/11 (73) 13/21 (62) 0.7
Headache 1/32 (3.1) 0/11 1/21 (4.8) >0.9
Asthenia/anorexia 16/33 (48) 4/12 (33) 12/21 (57) 0.3
Abdominal pain 11/33 (33) 7/12 (58) 4/21 (19) 0.052
Confusion 8/31 (26) 2/10 (20) 6/21 (29) >0.9
Dyspnea, respiratory rate >22 cycles/min 8/31 (26) 1/10 (10) 7/21 (33) 0.2
Hypotension, systolic pressure <100 mm Hg 7/31 (23) 1/10 (10) 6/21 (29) 0.4
qSOFA score 0.4
0 20/31 (65) 8/10 (80) 12/21 (57)
1 3/31 (10) 1/10 (10) 2/21 (10)
2 6/31 (19) 0/10 6/21 (29)
3 2/31 (6.5) 1/10 (10) 1/21 (4.8)
Sepsis: qSOFA ≥2 8/31 (26) 1/10 (10) 7/21 (33) 0.22
Diarrhea, n = 33
Total 16/33 (48) 10/12 (83) 6/21 (29) 0.004
Liquid 14/33 (42) 9/12 (75) 5/21 (24) 0.009
Bloody
2/33 (6.1)
1/12 (8.3)
1/21 (4.8)
>0.9
Laboratory and imaging findings
Leukocyte count, cells/mm3 (SD); reference range 4,000–10,000 cells/mm3 12,387 (6,665) 9,949 (3,307) 13,548 (7,571) 0.076
CRP, mg/L (SD), reference range <5 mg/L 118 (79) 120 (52) 116 (93) 0.9
Peripheral blood culture
No. (SD) NA NA 2.52 (1.63) NA
Negativation, d (SD)
NA
NA
2.89 (3.14)
NA
Transthoracic echocardiography**
4/32 (12)
1/11 (9.1)
3/21 (14)
>0.9
18F-FDG PET/CT 3/32 (9.4) 0/11 (0) 3/21 (14) 0.5

*Values are no./total (%) except as indicated. Boldface indicates p<0.05 or a significant trend defined by p<0.06. Blank cells for p values indicate no p value was calculated. 18F-FDG PET/CT, 18F-fluoro-deoxyglucose-positron emission tomography/computed tomography; CRP, C-reactive protein; qSOFA, quick sequential organ failure assessment; NA, not applicable. †Campylobacter fetus was isolated from 11 fecal cultures and from 1 bile fluid culture; only 1 patient had simultaneous positive peripheral blood and fecal cultures in which C. fetus was isolated with the same antimicrobial testing susceptibility pattern. ‡All patients with connective tissue diseases (bacteremia; n = 2) had multiple sclerosis. §Defined by hematologic diseases, long-term steroid therapy, or immunomodulatory treatment. ¶Defined by cardiac failure, arrhythmia, coronary heart disease, stroke, peripheral arterial obstructive disease and thromboembolic disease. #28-y-old patient sought care for bloody diarrhea without fever 8 d after a travel in Spain. **The 3 patients who underwent transthoracic echocardiography were different patients than those who underwent 18F-FDG PET/CT. No patient had both endocarditis and mycotic aneurysm.